From mild cognitive impairment to prodromal Alzheimer disease: A nosological evolution

European Geriatric Medicine

Volumn 1, Issue 3, 2010, Pages 146-154

  Molinuevo, J L ^a,b   Valls Pedret, C ^a   Rami, L ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alzheimer disease; Biomarkers; Brain imaging; MCI; Prodromal Alzheimer disease

Indexed keywords

NOOTROPIC AGENT;

ALZHEIMER DISEASE; CLINICAL FEATURE; DEMENTIA; DISEASE SEVERITY; HUMAN; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; REVIEW; RISK FACTOR;

EID: 77957849766     PISSN: 18787649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurger.2010.05.003     Document Type: Article

References (96)

1. V.A. Kral Senescent forgetfulness: benign and malignant Can Med Assoc J 86 1962 257 260
2. T. Crook, R.T. Bartus, and S.H. Ferris Age associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National institute of mental health work group Dev Neuropsychol 2 1986 261 276
3. R.C. Blackford, and A. La Rue Criteria for diagnosing age associated memory impairment: proposed improvements from the field Dev Neuropsychol 5 1989 295 296
4. C. Flicker, S.H. Ferris, and B. Resiberg Mild cognitive impairment in the elderly: predictors of dementia Neurology 41 1991 1006 1009
5. R.C. Petersen, G.E. Smith, and S.C. Waring Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308 (Pubitemid 29120227)
6. R.C. Petersen, R. Doody, and A. Kurz Current concepts in mild cognitive impairment Arch Neurol 58 2001 1985 1992 (Pubitemid 33143977)
7. R.C. Petersen, and J.C. Morris Mild cognitive impairment as clinical entity and a target for treatment Arch Neurol 62 2005 1160 1163 (Pubitemid 41043744)
8. K. Yaffe, R.C. Petersen, and K. Lindquist Subtype of mild cognitive impairment and progression to dementia and death Dement Geriatr Cogn Disord 22 2006 312 319 (Pubitemid 44651445)
9. S.M. Rasquin, J. Lodder, and P.J. Visser Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study Dement Geriatr Cogn Disord 19 2005 113 119 (Pubitemid 40868037)
10. A. Busse, A. Hensel, and U. Guhne Mild cognitive impairment: long-term course of four clinical subtypes Neurology 67 2006 2176 2185 (Pubitemid 46035473)
11. O.L. Lopez, W.J. Jagust, and S.T. DeKosky Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study: part 1 Arch Neurol 60 2003 1385 1389 (Pubitemid 37248799)
12. M. Ganguli, H.H. Dodge, and C. Shen Mild cognitive impairment, amnestic type: an epidemiologic study Neurology 63 1 2004 15 21 (Pubitemid 38943788)
13. K. Ritchie Mild cognitive impairment an epidemiological perspective Dialogues Clin Neurosci 6 2004 401 408 (Pubitemid 40052071)
14. A. Burns, and M. Zaudig Mild cognitive impairment in older people Lancet 360 2002 1963 1965 (Pubitemid 35472141)
15. K. Ritchie, S. Artero, and J. Touchon Classification criteria for mild cognitive impairment: a population-based validation study Neurology 56 2001 37 42 (Pubitemid 32059649)
16. P. Fischer, S. Jungwirth, and S. Zehetmayer Conversion from subtypes of mild cognitive impairment to Alzheimer dementia Neurology 68 2007 288 291 (Pubitemid 46148341)
17. O.L. López, J.T. Becker, and W.J. Jagust Neuropsychological characteristics of mild cognitive impairment subgroups J Neurol Neurosurg Psychiatry 77 2006 159 165 (Pubitemid 43220834)
18. B. Winblad, K. Palmer, and M. Kivipelto Mild cognitive impairment - beyond controversies, towards a consensus: report of the international group on mild cognitive impairment J Intern Med 256 2004 240 246 (Pubitemid 39222993)
19. F.E. de Leeuw, J.C. de Groot, and M. Oudkerk Hypertension and cerebral white matter lesions in a prospective cohort study Brain 125 2002 765 772 (Pubitemid 34279772)
20. C. MacKnight, K. Rockwood, and E. Awalt Diabetes mellitus and the risk of dementia Alzheimer's disease and vascular cognitive impairment in the Canadian study of health and aging Dement Geriat Cogn Disord 14 2002 77 83 (Pubitemid 36152948)
21. B. Segura, M.A. Jurado, and N. Freixenet Microstructural white matter changes in metabolic syndrome Neurology 73 2009 438 444
22. M.M. Breteler, J.C. van Swieten, and M.L. Bots Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study Neurology 44 1994 1246 1252 (Pubitemid 24232223)
23. J.M. Serra-Grabulosa, P. Salgado-Pineda, and C. Junqué Apolipoproteins E and C1 and brain morphology in memory impaired elders Neurogenetics 4 2003 141 146 (Pubitemid 36612197)
24. M. Lehtovirta, M.P. Laakso, and G.B. Frisoni How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies Neurobiol Aging 21 2000 293 300 (Pubitemid 30387088)
25. D. Bartrés-Faz, J.M. Serra-Grabulosa, and F.T. Sun Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE epsilon 4 allele Neurobiol Aging 29 2008 1644 1653
26. E.M. Reiman, K.W. Chen, and X.F. Liu Fibrillar amyloid-beta burden in cognitively normal people at three levels of genetic risk for Alzheimer's disease PNAS 106 2009 6820 6825
27. Y. Stern, S. Albert, and M.X. Tang Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 53 1999 1942 1947
28. B.L. Plassman, K.A. Welsh, and M. Helms Intelligence and education as predictors of cognitive state in late-life. A 50-year follow-up Neurology 45 1995 1446 1450
29. Y. Stern, B. Gurland, and T.K. Tatemichi Influence of education and occupation on incidence of Alzheimers-disease JAMA 271 1994 1004 1010 (Pubitemid 24099921)
30. E.P. Helzner, N. Scarmeas, and S. Cosentino Leisure activity and cognitive decline in incident Alzheimer disease Arch Neurol 64 2007 1749 1754 (Pubitemid 350254937)
31. C. Féart, C. Samieri, and V. Rondeau Adherence to a Mediterranean diet, cognitive decline and risk of dementia JAMA 302 2009 638 648
32. N. Scarmeas, J.A. Luchsinger, and N. Schupf Physical activity, diet and risk of Alzheimer disease JAMA 302 2009 627 637
33. C.R. Jack, R.C. Petersen, and Y.C. Xu Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 1999 1397 1403
34. G. Chételat, B. Desgranges, and V. de la Sayette Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment Neuroreport 13 2002 1939 1943 (Pubitemid 35398965)
35. C. Pennanen, C. Testa, and M.P. Laakso A voxel-based morphometry study on mild cognitive impairment J Neurol Neurosurg Psychiatry 76 2005 11 14 (Pubitemid 40013484)
36. K.M. Rodriguez, and N. Raz Shrinkage of the entorhinal cortex over 5 years predicts memory performance in healthy adults J Neurosci 24 2004 956 963 (Pubitemid 38146606)
37. T. Hedden, and J.D.E. Gabrieli Insights into the aging mind: a view from cognitive neuroscience Nat Rev Neurosci 5 2004 87 97 (Pubitemid 38160284)
38. C. Pennanen, M. Kivipelto, and S. Tuomainen Hippocampus and entorhinal cortex in mild cognitive impairment and early AD Neurobiol Aging 25 2004 303 310 (Pubitemid 38220965)
39. M. Yoshita, E. Fletcher, and D. Harvey Extent and distribution of white matter hyperintensities in normal aging. MCI and AD Neurology 67 2006 2192 2198 (Pubitemid 46035476)
40. A. Pfefferbaum, E. Adalsteisson, and E. Sullivan Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging Neuroimage 26 2005 891 899 (Pubitemid 40825031)
41. D. Medina, L. de Toledo-Morell, and F. Urresta White matter changes in mild cognitive impariment and AD: a diffusion tensor imaging study Neurobiol Aging 27 2006 663 672
42. A. Fellgiebel, M. Müller, and P. Wille Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment Neurobiol Aging 26 2005 1193 1198 (Pubitemid 40726012)
43. B. Bosch, E.M. Arenaza-Urquijo, and L. Rami Multiple DTI index analysis in normal aging, amnestic MCI and AD Relationship with neuropsychological performance Neurobiol Aging 2010 [Epub ahead of print]
44. P. Kalus, J. Slotboom, and J. Gallinat Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia Neuroimage 30 2006 713 720
45. M.M. Machulda, H.A. Ward, and B. Borowski Comparison of memory fMRI response among normal MCI and Alzheimer's patients Neurology 61 2003 500 506 (Pubitemid 37025367)
46. B.C. Dickerson, D.H. Salat, and D.N. Greve Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD Neurology 65 2005 404 411
47. A. Hämäläinen, M. Pihlajamaki, and H. Tanila Increased fMRI responses during encoding in mild cognitive impairment Neurobiol Aging 28 2007 1889 1903 (Pubitemid 47539695)
48. C. Solé-Padullés, D. Bartrés-Faz, and C. Junqué Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease Neurobiol Aging 30 2009 1114 1124
49. D. Bartrés-Faz, C. Solé-Padullés, and C. Junqué Interactions of cognitive reserve with regional brain anatomy and brain function during a working memory task in healthy elders Biol Psychol 80 2009 256 259
50. B. Bosch, D. Bartrés-Faz, and L. Rami Cognitive reserve modulates task-induced activations and deactivations un healthy elders, amnestic mild cognitive impairment and mild Alzheimer' disease Cortex 46 2010 451 461
51. P. Celsis, A. Agniel, and D. Cardebat Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance J Neurol Neurosurg Psychiatry 62 1997 601 608 (Pubitemid 27281263)
52. S. Minoshima, B. Giordani, and S. Berent Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's diease Ann Neurol 42 1997 85 94 (Pubitemid 27304784)
53. D.A. Wolk, J.C. Price, and J.A. Saxton Amyloid imaging in mild cognitive impairment subtypes Ann Neurol 65 2009 557 568
54. S.S. Mirra, A. Heyman, and D. McKeel The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486 (Pubitemid 19239715)
55. G.A. Jicha, J.E. Parisi, and D.W. Dickson Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia Arch Neurol 63 2006 674 681
56. R.C. Petersen, J.E. Parisi, and D.W. Dickson Neuropathologic features of amnestic mild cognitive impairment Arch Neurol 63 2006 665 672
57. B. Dubois Prodromal Alzheimer's disease": a more useful concept than mild cognitive impairment? Curr Opi Neurol 13 2000 367 369
58. B. Dubois, and M.L. Albert Amnestic MCI or Prodromal Alzheimer's disease? Lancet Neurol 3 2004 246 248 (Pubitemid 38373663)
59. L. Rami, B. Gómez-Anson, and R. Sanchez-Valle Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features Dement Geriatr Cogn Disord 24 2007 402 410 (Pubitemid 350036698)
60. M.C. Tierney, J.P. Szalai, and W.G. Snow The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits Arch Neurol 53 1996 423 427
61. K. Peres, V. Chrysostome, and C. Fabrigoule Restriction in complex activities of daily living in MCI: impact on outcome Neurology 67 2006 461 466 (Pubitemid 44214971)
62. A. Bozoki, B. Giordani, and J. Heidebrink Mild cognitive impairments predict dementia in non demented elderly patients with memory loss Arch Neurol 58 2001 411 416 (Pubitemid 32217457)
63. L. Rami, B. Gómez-Anson, and G.C. Monte Voxel based morphometry features and follow-up of amnestic patients at high risk for Alzheimer's disease conversion Int J Geriatr Psychiatry 24 2009 875 884
64. C. DeCarli, G.B. Frisoni, and C.M. Clark Alzheimer's disease cooperative study group qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia Arch Neurol 64 2007 108 115
65. D.P. Devanand, G. Pradhaban, and X. Liu Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease Neurology 68 2007 828 836 (Pubitemid 46568534)
66. E. Arnaiz, O. Almkvist, and R.J. Ivnik Mild cognitive impairment: a cross-national comparison J Neurol Neurosurg Psychiatry 75 2004 1275 1280 (Pubitemid 39141332)
67. B. Dubois, H.H. Feldman, and C. Jacova Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet 6 2007 734 746 (Pubitemid 47058377)
68. M. Sarazin, C. Berr, and J. De Rotrou Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study Neurology 69 2007 1859 1867 (Pubitemid 350071147)
69. G.B. Frisoni, S. Galluzzi, and M. Signorini Preliminary evidence of validity of the revised criteria for Alzheimer disease diagnosis: report of two cases Alzheimer Dis Assoc Disord 24 2010 108 114
70. H. Tounsi, B. Deweer, and A.M. Ergis Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease Alzheimer Dis Assoc Disord 13 1999 38 46 (Pubitemid 29176521)
71. J.L. Molinuevo, B. Gómez-Anson, and G.C. Monte Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates Arch Gerontol Geriatr 2010 [Epub ahead of print]
72. H. Braak, and E. Braak Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 1991 [23 9-5 9]
73. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
74. W.L. Klein, W.B. Stine Jr., and D.B. Teplow Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease Neurobiol Aging 25 2004 569 580
75. S. Oddo, A. Caccamo, and L. Tran Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease A link between Aβ and tau pathology J Biol Chem 281 2006 1599 1604 (Pubitemid 43752475)
76. W.E. Klunk, H. Engler, and A. Nordberg Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B Ann Neurol 55 2004 306 319 (Pubitemid 38269583)
77. C.C. Rowe, S. Ng, and U. Ackermann Imaging beta-amyloid burden in aging and dementia Neurology 68 2007 1718 1725 (Pubitemid 46763260)
78. P. Edison, H.A. Archer, and R. Hinz Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDGPET study Neurology 68 2007 501 508 (Pubitemid 46263180)
79. C.M. Clark, S. Xie, and J. Chittams Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60 2003 1696 1702 (Pubitemid 37521622)
80. D. Strozyk, K. Blennow, and L.R. White CSF Aβ 42 levels correlate with amyloidneuropathology in a population-based autopsy study Neurology 60 2003 652 656 (Pubitemid 36246085)
81. N.S. Schoonenboom, W.M. van der Flier, and M.A. Blankenstein CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease Neurobiol Aging 29 2008 669 675 (Pubitemid 351400823)
82. H. Arai, M. Terajima, and M. Miura Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease Ann Neurol 38 1995 649 652 (Pubitemid 26391089)
83. K. Blennow, A. Wallin, and H. Agren Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26 1995 231 245 (Pubitemid 26002016)
84. T. Tapiola, M. Overmyer, and M. Lehtovirta The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease Neuroreport 8 1997 3961 3963 (Pubitemid 28027217)
85. K. Buerger, M. Ewers, and T. Pirttila CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease Brain 129 2006 3035 3041 (Pubitemid 44684523)
86. A. Mitchell, and N. Brindle CSF phosphorylated tau - does it constitute an accurate biological test for Alzheimer's disease? Int J Geriat Psychiatry 18 2003 407 411 (Pubitemid 36637180)
87. K. Blennow, H. Hampel, and M. Weiner Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 2010 131 144
88. L.M. Shaw, H. Vanderstichele, and M. Knapik-Czajka Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
89. P.J. Visser, F. Verhey, and D.L. Knol Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study Lancet Neurol 8 2009 619 627
90. N. Mattsson, H. Zetterberg, and O. Hansson CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 2009 385 393
91. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet Neurol 368 2006 387 403 (Pubitemid 44108123)
92. A.M. Fagan, C.M. Roe, and C. Xiong Cerebrospinal fluid tau/beta-amyloid (42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 2007 343 349 (Pubitemid 46425688)
93. M.J. de Leon, S. DeSanti, and R. Zinkowski Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment Neurobiol Aging 27 3 2006 94 401 (Pubitemid 43185324)
94. M.J. de Leon, S. Segal, and C.Y. Tarshish Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment Neurosci Lett 333 2002 183 186 (Pubitemid 35335773)
95. A. Norberg Amyloid imaging in early detection of Alzheimer's disease Neurodegener Dis 7 2010 136 138
96. N.L. Foster A new framework for the diagnosis of Alzheimer's disease Lancet Neurol 6 2007 667 669 (Pubitemid 47058378)